2012
Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth
Yonkers KA, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E, Lin H, Belanger K. Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth. Epidemiology 2012, 23: 677-685. PMID: 22627901, PMCID: PMC3415566, DOI: 10.1097/ede.0b013e31825838e9.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitorsMajor depressive episodePreterm birthDepressive episodeLogistic regressionSRI useUse of SRIsSerotonin reuptake inhibitor treatmentReuptake inhibitor treatmentEarly preterm birthLate preterm birthProspective cohort studyPreterm birth riskMajor depressive disorderNominal logistic regressionBinary logistic regressionAntidepressant treatmentCohort studyHospital chartsReuptake inhibitorsSymptomatic womenBirth outcomesPregnant womenRisk factorsDepressive disorder
2005
Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study
Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB. Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study. American Journal Of Psychiatry 2005, 162: 1179-1187. PMID: 15930067, PMCID: PMC3272761, DOI: 10.1176/appi.ajp.162.6.1179.Peer-Reviewed Original ResearchConceptsComorbid psychiatric disordersClinical courseAnxiety disordersPanic disorderPsychiatric disordersHarvard/Brown Anxiety Disorders Research ProgramLong-term clinical courseProportional hazards regression analysisOverall clinical courseChronic clinical courseHazards regression analysisSocial phobiaComorbid psychiatric conditionsStandard survival analysis methodsGeneralized anxiety disorderLikelihood of recoveryChronic courseProspective studyMulticenter studyPsychiatric comorbidityRisk ratioMajor depressionRecurrencePsychiatric predictorsSurvival analysisPretreatment pattern of symptom expression in premenstrual dysphoric disorder
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal Of Affective Disorders 2005, 85: 275-282. PMID: 15780697, DOI: 10.1016/j.jad.2004.10.004.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderPMDD symptomsMenstrual cycleDysphoric disorderPatient variabilityIntermittent dosing strategyOnset of menstruationDSM-IV criteriaPatients' durationAnxiety/tensionSertraline treatmentDRSP scoresPatient daysDosing strategiesSevere symptomsDay 2SymptomsTreatment studiesPretreatment patternAnger/irritabilityMood swingsMore daysWomenSymptom expressionTreatment implications
2003
Chronicity, relapse, and illness—course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow‐up
Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness—course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow‐up. Depression And Anxiety 2003, 17: 173-179. PMID: 12768651, DOI: 10.1002/da.10106.Peer-Reviewed Original ResearchConceptsHarvard/Brown Anxiety Research ProgramClinical courseRelapse rateUncomplicated panic disorderPanic disorderAnxiety disordersRelapse eventsSex differencesSocial phobiaCumulative remission rateMajority of menFrequent remissionsRemission ratePrognostic implicationsChronic illnessRelapse statusRemissionYears of observationPatientsEnduring illnessSame cohortSignificant sex differencesMonth intervalsIllnessObservation period
2002
Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Halbreich U, Bergeron R, Yonkers K, Freeman E, Stout A, Cohen L. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstetrics And Gynecology 2002, 100: 1219-29. PMID: 12468166, DOI: 10.1016/s0029-7844(02)02326-8.Peer-Reviewed Original Research